Albert Vilella, PhD.
@albertvilella.bsky.social
42K followers 130K following 2.6K posts
Bioinformatics Scientist / Next Generation Sequencing, Single Cell and Spatial Biology, Next Generation Proteomics, Liquid Biopsy, SynBio, Compute Acceleration in biotech // http://albertvilella.substack.com
Posts Media Videos Starter Packs
albertvilella.bsky.social
I just posted this graph on bluesky this week: I think it was very illuminating of the bubbly state of AI recently.
albertvilella.bsky.social
@andrewpannu, not on bluesky, on the BMS deal
albertvilella.bsky.social
MI355X vLLM is seeing competitive perf per TCO compared to B200 vLLM
Reposted by Albert Vilella, PhD.
aphclarkson.bsky.social
If this is happening at the Centre for Disease Control and military troops are going to foodbanks, imagine the condition US government agencies are in that are tasked with managing financial market risks
albertvilella.bsky.social
The power efficiency of Nvidia GB200 chips
albertvilella.bsky.social
The who is who in #AI and the big deals
albertvilella.bsky.social
@nicholemather, not on #Bluesky, on the appointment as new Scientific Advisory Board head at the @wellcometrust.bsky.social Genome Campus in Cambridge
albertvilella.bsky.social
@drsamuelbhume, not on #Bluesky, on Another approval for anti-PD1 immunotherapy:

Cemiplimab just got FDA-approved to reduce recurrence of high-risk squamous cell skin cancer (after surgery and radiotherapy)

It was based on these impressive phase 3 data:
albertvilella.bsky.social
1 min of vigorous = 7.8 mins of moderate = 73 minutes of light (CVD risk).
albertvilella.bsky.social
1 minute of vigorous = 9.4 minutes of moderate = 94 minutes of light intensity activities (type 2 diabetes risk)
albertvilella.bsky.social
@estamatakis.bsky.social , not recently active on #Bluesky, on the health value of each minute of different physical activity intensities against 6 health outcomes.
albertvilella.bsky.social
AlphafoldDB updates, now includes MSAs